[HTML][HTML] Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious …
SC Mellinghoff, J Panse, N Alakel, G Behre… - Annals of …, 2018 - Springer
Immunocompromised patients are at high risk of invasive fungal infections (IFI), in particular
those with haematological malignancies undergoing remission-induction chemotherapy for …
those with haematological malignancies undergoing remission-induction chemotherapy for …
Resistance to antifungal agents: mechanisms and clinical impact
ZA Kanafani, JR Perfect - Clinical infectious diseases, 2008 - academic.oup.com
Despite advances in preventive, diagnostic, and therapeutic interventions, invasive fungal
infections cause significant morbidity and mortality in immunocompromised patients. The …
infections cause significant morbidity and mortality in immunocompromised patients. The …
[HTML][HTML] Population-based analysis of invasive fungal infections, France, 2001–2010
D Bitar, O Lortholary, Y Le Strat, J Nicolau… - Emerging infectious …, 2014 - ncbi.nlm.nih.gov
To determine the epidemiology and trends of invasive fungal infections (IFIs) in France, we
analyzed incidence, risk factors, and in-hospital death rates related to the most frequent IFIs …
analyzed incidence, risk factors, and in-hospital death rates related to the most frequent IFIs …
[HTML][HTML] An insight into the antifungal pipeline: selected new molecules and beyond
L Ostrosky-Zeichner, A Casadevall… - Nature reviews Drug …, 2010 - nature.com
Invasive fungal infections are increasing in incidence and are associated with substantial
mortality. Improved diagnostics and the availability of new antifungals have revolutionized …
mortality. Improved diagnostics and the availability of new antifungals have revolutionized …
Antifungal peptides: To be or not to be membrane active
M Rautenbach, AM Troskie, JA Vosloo - Biochimie, 2016 - Elsevier
Most antifungal peptides (AFPs), if not all, have membrane activity, while some also have
alternative targets. Fungal membranes share many characteristics with mammalian …
alternative targets. Fungal membranes share many characteristics with mammalian …
The current spectrum of infection in cancer patients with chemotherapy related neutropenia
L Nesher, KVI Rolston - Infection, 2014 - Springer
Despite advancements in the treatment and supportive care of patients with malignant
disorders, neutropenia remains the major side effect of most antineoplastic regimens …
disorders, neutropenia remains the major side effect of most antineoplastic regimens …
[HTML][HTML] Ocimum sanctum essential oil and its active principles exert their antifungal activity by disrupting ergosterol biosynthesis and membrane integrity
The increasing incidence of drug-resistant pathogens and host toxicity of existing antifungals
attracts attention toward the efficacy of natural products as antifungals in mucocutaneous …
attracts attention toward the efficacy of natural products as antifungals in mucocutaneous …
[HTML][HTML] Yeasts in the gut: from commensals to infectious agents
J Schulze, U Sonnenborn - Deutsches Ärzteblatt International, 2009 - ncbi.nlm.nih.gov
Background Controversy still surrounds the question whether yeasts found in the gut are
causally related to disease, constitute a health hazard, or require treatment. Methods The …
causally related to disease, constitute a health hazard, or require treatment. Methods The …
[HTML][HTML] Protection by anti-β-glucan antibodies is associated with restricted β-1, 3 glucan binding specificity and inhibition of fungal growth and adherence
A Torosantucci, P Chiani, C Bromuro, F De Bernardis… - PloS one, 2009 - journals.plos.org
Anti-β-glucan antibodies elicited by a laminarin-conjugate vaccine confer cross-protection to
mice challenged with major fungal pathogens such as Candida albicans, Aspergillus …
mice challenged with major fungal pathogens such as Candida albicans, Aspergillus …
[HTML][HTML] Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature
MD Mignogna, G Fortuna, S Leuci, D Adamo… - International Journal of …, 2011 - Elsevier
OBJECTIVES: To review the current literature on mucormycosis in immunocompentent/
otherwise healthy individuals, to which five new cases with maxillary sinus involvement have …
otherwise healthy individuals, to which five new cases with maxillary sinus involvement have …